Fibromyalgia: Open Access
Open Access

Advances in Fibromyalgia Medication

Search results for
Advances in Fibromyalgia Medication

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Awards & Nominations
Publication Policies and Ethics
Indexed In
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
View More
Useful Links
Share This Page

Advances in Fibromyalgia Medication

A new drug was Cymbalta (duloxetine), Savella (milnacipran) and Lyrica (pregabalin). Gamma Hydroxybutyrate was also introduced but it was later withdrawn by the FDA because of its high abuse potential.

Related journals of Advances in Fibromyalgia Medication

Fibromyalgia: Open Access, Journal of Arthritis, International Journal of Physical Medicine & Rehabilitation, Rheumatology: Current Research, Journal of Sports Medicine & Doping Studies, International Journal of Ayurvedic and Herbal Medicine, Journal of Alternative and Complementary Medicine, Journal of Ayurveda and Integrative Medicine, International Journal of Ayurvedic Medicine, International Journal of Research in Ayurveda and Pharmacy.

Advances in Fibromyalgia Medication

Expert PPTs

Speaker PPTs

High Impact List of Articles
Conference Proceedings